NCT03607890 2026-03-16
Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Active not recruiting
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
Replimune Inc.
ImmunityBio, Inc.
AIO-Studien-gGmbH
M.D. Anderson Cancer Center